Not yet recruitingPhase 2NCT07871214
A Study to Assess The Safety and Tolerability of Pumitamig-Based Therapy Administered Before Surgery in Participants With Early-Stage Non-Small Cell Lung Cancer (ROSETTA Lung-220)
Sponsor: Bristol-Myers Squibb
Chestnut Hill, MA · +8 more sites